Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

About 2% of U.S. adults use GLP-1 drugs, but results vary. Diet, exercise, and mental health remain key to long-term success.

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

Alabama Barker is showing some cheek in her Pucci swimsuit and matching hair bow, but her photos are sparking Ozempic rumors.